Gland Pharma consolidated net profit rises 47.09% in the June 2026 quarter

Sales rise 19.57% to Rs 1800.27 crore

Net profit of Gland Pharma rose 47.09% to Rs 316.96 crore in the quarter ended June 2026 as against Rs 215.48 crore during the previous quarter ended June 2025. Sales rose 19.57% to Rs 1800.27 crore in the quarter ended June 2026 as against Rs 1505.62 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	1800.27	1505.62	20
OPM %	27.18	24.43	-
PBDT	546.23	413.79	32
PBT	434.98	312.74	39
NP	316.96	215.48	47

Powered by Capital Market - Live News